FAP and neoplasm: Together, in this study, we identified the potent antitumor effects of FAP-targeted and CLDN18.2-targeted CAR-T cells sequential therapy in murine pancreatic cancer models at least partially through the improved accumulation of CAR-T cells and reduced recruitments of MDSCs to the tumor sites.